Clinical Trial Update: 1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Bremelanotide in premenopausal women with hypoactive sexual desire disorder has completed and results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoactive Sexual Desire Disorder

Drugs mentioned

• Bremelanotide (bremelanotide)

Snippet

Sponsor: Palatin Technologies, Inc | Conditions: Hypoactive Sexual Desire Disorder | Phase 3 | Status: COMPLETED | Results posted: 2020-12-23